Unity Biotechnology, Inc. (UBX) Latest Stock News & Headlines
Get the latest Unity Biotechnology, Inc. (UBX) stock news and headlines to help you in your trading and investing decisions.
UNITY Biotechnology Reports Granting of New Employment …
2 days ago · SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...
UNITY Biotechnology Announces Appointment of Federico …
4 days ago · SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging ...
Unity Biotechnology Inc. - MarketWatch
2 days ago · UBX | Complete Unity Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Unity Biotechnology Names Federico Grossi Chief Medical …
3 days ago · (RTTNews) - Shares of Unity Biotechnology, Inc. (UBX) are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical Officer.
UNITY Biotechnology Announces Appointment of Federico …
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development and ...
Home | Unity Biotechnology
At UNITY we are advancing the first senolytic therapeutic for retinal diseases. Lead senolytic candidate UBX1325 has a novel mechanism of action that potentially provides longer lasting improvements in vision compared to current standard of care for diabetic macular edema.
Unity Biotechnology (UBX) Stock Price, News & Analysis
2 days ago · MarketBeat has tracked 6 news articles for Unity Biotechnology this week, compared to 0 articles on an average week. 3 people have searched for UBX on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. 2 people have added Unity Biotechnology to their MarketBeat watchlist in the last 30 days.
UNITY Biotechnology Announces Results from Phase 2 …
Mar 27, 2023 · UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
Unity Biotechnology, Inc. (UBX) Stock Price, Quote & News
4 days ago · Get a real-time Unity Biotechnology, Inc. (UBX) stock price quote with breaking news, financials, statistics, charts and more.